Your browser doesn't support javascript.
loading
Neutralizing antibodies with neurotropic factor treatment maintain neurodevelopmental gene expression upon exposure to human cytomegalovirus.
O'Brien, Benjamin S; Mokry, Rebekah L; Schumacher, Megan L; Rosas-Rogers, Suzette; Terhune, Scott S; Ebert, Allison D.
Affiliation
  • O'Brien BS; Department of Cell Biology, Neurobiology, and Anatomy, The Medical College of Wisconsin , Milwaukee, Wisconsin, USA.
  • Mokry RL; Department of Microbiology and Immunology, The Medical College of Wisconsin , Milwaukee, Wisconsin, USA.
  • Schumacher ML; Department of Microbiology and Immunology, The Medical College of Wisconsin , Milwaukee, Wisconsin, USA.
  • Rosas-Rogers S; Department of Microbiology and Immunology, The Medical College of Wisconsin , Milwaukee, Wisconsin, USA.
  • Terhune SS; Department of Microbiology and Immunology, The Medical College of Wisconsin , Milwaukee, Wisconsin, USA.
  • Ebert AD; Marquette University and Medical College of Wisconsin Department of Biomedical Engineering, Medical College of Wisconsin , Milwaukee, Wisconsin, USA.
J Virol ; 97(10): e0069623, 2023 10 31.
Article in En | MEDLINE | ID: mdl-37796129
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression / Cytomegalovirus Infections / Cytomegalovirus / Antibodies, Neutralizing / Nerve Growth Factors Limits: Humans Language: En Journal: J Virol Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Expression / Cytomegalovirus Infections / Cytomegalovirus / Antibodies, Neutralizing / Nerve Growth Factors Limits: Humans Language: En Journal: J Virol Year: 2023 Document type: Article